About Index Trending news
Analyze
Top 50 Pricing
Inotek Pharmaceuticals

Inotek Pharmaceuticals

Work at Inotek Pharmaceuticals? Add yourself to this profile

Inotek Pharmaceuticals

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

Elsewhere

Alexa global traffic share

Latest funding Show all
Debt financing
$7,000,000
Venture capital (Series D)
$23,600,000
Employees

Unknown size

The Motley Fool

Why Inotek Pharmaceuticals Corporation Stock Rose 28.4% in April